Olivier Litzka - Profile and Investment Details

Investor Profile

Olivier Litzka is a Venture Capital, Private Equity Firm, Investor based in Germany with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma, AM Pharma, MedDay, HighLifeGroupe ADF, SuperSonic Imagine, Groupe JORYF, Sogetrel, Biogroup-LCD, MMI, Thomson Video Networks, Crescendo Biologics, Netco, Bacacier group, ACE Group, Complexa, walor, Ipside, Genkyotex, Complix, ace credit, SANIFIT, Atlantic Therapeutics, Altavia, Verona Pharma, Chase Pharmaceuticals, Loyalty Company, The Bioclinic Group, Groupe 3S, T-knife, Endosense, Poxel, HR Path, Axonics Modulation Technologies, La Vie Saine, Sfam, Mondial Pet Distribution, Sirsa, ReViral, In'Tech Medical, Inotrem, A2IA, Opportunity, Artios Pharma, GamaMabs Pharma, Corvidia, Mastergrid, Minafin, Maesa Group, Finsecur, orbility, Solware Group, Exciva, Covagen, Avalyn Pharma, LogicBio Therapeutics, erytech, Groupe ERGET, 3i Group plc, Atland, Medlumics, TargED Biopharmaceuticals, The Reefer Group, Studia group, Travelsoft, REALEASE Capital, Rougnon, Fortesan, La Toulousaine, Grey Wolf Therapeutics, Globe Groupe, Autonomic Technologies, Tournus Equipement, JenaValve Technology, SPHEREA, Vivoryon Therapeutics, Allecra Therapeutics, MS Vacances, Passman, Emeraude International, Dynacure, Tricares, Pennel & Flipo, AgomAb Therapeutics, Arvelle Therapeutics, . Over time, Olivier Litzka has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Olivier Litzka is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, CRM, Life Science, Robotics, Information Technology (IT), Biotechnology, FinTech, Consulting, Medical, SaaS, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Olivier Litzka, as their portfolio suggests a familiarity and interest in this area.

Understanding Olivier Litzka’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.